A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso  ¹     Marco Ventimiglia  ¹     Walter Fries  ²     Maria Cappello  ³     Barbara Scrivo  ⁴     Antonio Magnano     Dario Pluchino     Salvatore Camilleri     Serena Garufi     Roberto Di Mitri     Filippo Mocciaro     Giovanni Magri     Concetta Ferracane     Michele Citrano     Francesco Graziano     Carmelo Bertolami     Sara Renna     Rosalba Orlando     Giulia    
¹ 'Villa Sofia-Cervello' Hospital,Palermo (Pa),Italy
² Inflammatory Bowel Disease Unit, A.O.U. Policlinico 'G. Martino”,Messina,Italy
³ UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palermo,Palermo,Italy
⁴ UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palerm

Session
IBD II (Posters)

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019